The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Epidemiology and risk factors for kidney cancer
Open accessAbstract
After more than two decades of rising rates, in recent years the total kidney cancer incidence worldwide has shown signs of stabilizing, or even decreasing. In adults, kidney cancer consists of renal cell carcinoma (RCC), the predominant form, and renal transitional cell carcinoma (RTCC); these types primarily arise in the renal parenchyma and renal pelvis, respectively. Although temporal trends by kidney cancer type are not well established worldwide, incidence of RCC in the US has continued to rise, mainly for early-stage tumors, while that of RTCC has declined, and total kidney cancer mortality rates have leveled. Stabilization of kidney cancer mortality rates has also been reported in Europe. These trends are consistent with reports of increasing incidental diagnoses and a downward shift in tumor stage and size in clinical series. The changing prevalence of known risk factors for RCC, including cigarette smoking, obesity, and hypertension, is also likely to affect incidence trends, although their relative impact may differ between populations. Accumulating evidence suggests an etiologic role in RCC for physical activity, alcohol consumption, occupational exposure to trichloroethylene, and high parity among women, but further research is needed into the potential causal effects of these factors. Genetic factors and their interaction with environmental exposures are believed to influence risk of developing RCC, but a limited number of studies using candidate-gene approaches have not produced conclusive results. Large consortium efforts employing genome-wide scanning technology are underway, which hold promise for novel discoveries in renal carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · cited 1×
“In the US, the age-adjusted prevalence of obesity has not increased significantly among women since 1999, and among men since 2003”
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
The Health Consequences of Smoking: A Report of the Surgeon General
Office on Smoking (2004) · Cited by 2,414
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Cited by
Hsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D. Y., Larkin, J., & Ficarra, V. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.9 · Cited by 2,426
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Algaba, F., Patard, J. J., Khoo, V., Eisen, T., & Horwich, A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu259 · Cited by 2,251
Epidemiology of Renal Cell Carcinoma
Capitanio, U., Bensalah, K., Bex, A., Boorjian, S. A., Bray, F., Coleman, J., Gore, J. L., Sun, M., Wood, C., & Russo, P. (2019) · European Urology · doi:10.1016/j.eururo.2018.08.036 · Cited by 1,618
The relationship between different dimensions of alcohol use and the burden of disease—an update
Rehm, J., Gmel, G. E., Gmel, G., Hasan, O. S. M., Imtiaz, S., Popova, S., Probst, C., Roerecke, M., Room, R., Samokhvalov, A. V., et al. (2017) · Addiction · doi:10.1111/add.13757 · Cited by 1,204
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Rioux-Leclercq, N., Bex, A., Khoo, V., Grünwald, V., Gillessen, S., & Horwich, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz056 · Cited by 1,151
The Epidemiology of Renal Cell Carcinoma
Ljungberg, B., Campbell, S. C., Cho, H. Y., Jacqmin, D., Lee, J. E., Weikert, S., & Kiemeney, L. A. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.049 · Cited by 999
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Znaor, A., Lortet-Tieulent, J., Laversanne, M., Jemal, A., & Bray, F. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.002 · Cited by 984
Epidemiology of Renal Cell Carcinoma: 2022 Update
Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., Kassouf, W., Mitchell, T., Montironi, R., O'Brien, T., et al. (2022) · European Urology · doi:10.1016/j.eururo.2022.08.019 · Cited by 775
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Rioux-Leclercq, N., Bex, A., Khoo, V., Gruenvald, V., & Horwich, A. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw328 · Cited by 509
Ki-67 protein as a tumour proliferation marker
Menon, S. S., Guruvayoorappan, C., Sakthivel, K. M., & Rasmi, R. R. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.01.011 · Cited by 479
Global Burden of Urologic Cancers, 1990–2013
Dy, G. W., Gore, J. L., Forouzanfar, M. H., Naghavi, M., & Fitzmaurice, C. (2017) · European Urology · doi:10.1016/j.eururo.2016.10.008 · Cited by 373
Chittezhath, M., Dhillon, M. K., Lim, J. Y., Laoui, D., Shalova, I. N., Teo, Y. L., Chen, J., Kamaraj, R., Raman, L., Lum, J., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.014 · Cited by 308
Epidemiology and Risk Factors for Kidney Cancer
Scelo, G., & Larose, T. L. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.1905 · Cited by 305
Sun, M., Thuret, R., Abdollah, F., Lughezzani, G., Schmitges, J., Tian, Z., Shariat, S. F., Montorsi, F., Patard, J.-J., Perrotte, P., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.10.029 · Cited by 304
Heller, N. E., Sathianathen, N. J., Kalapara, A. A., Walczak, E. G., Moore, K., Kaluzniak, H., Rosenberg, J. E., Blake, P., Rengel, Z., Oestreich, M., et al. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1904.00445 · Cited by 300
Cancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001–2009
Siegel, D. A., King, J., Tai, E., Buchanan, N., Ajani, U. A., & Li, J. (2014) · Pediatrics · doi:10.1542/peds.2013-3926 · Cited by 275
von Roemeling, C. A., Marlow, L. A., Wei, J. J., Cooper, S. J., Caulfield, T. R., Wu, K., Tan, W. W., Tun, H. W., & Copland, J. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3249 · Cited by 273
Hippisley-Cox, J., & Coupland, C. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x616355 · Cited by 208
Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA
Schafer, E. J., Jemal, A., Wiese, D., Sung, H., Kratzer, T. B., Islami, F., Dahut, W. L., & Knudsen, K. E. (2023) · European Urology · doi:10.1016/j.eururo.2022.11.023 · Cited by 114
Franco, E. F., Rana, P., Cruz, A., Calderón, V. V., Azevedo, V., Ramos, R. T. J., & Ghosh, P. (2021) · Cancers · doi:10.3390/cancers13092013 · Cited by 92
Greene, C. J., Attwood, K., Sharma, N. J., Gross, K. W., Smith, G. J., Xu, B., & Kauffman, E. C. (2017) · Oncotarget · doi:10.18632/oncotarget.22323 · Cited by 87
Krishnan, B., Rose, T. L., Kardos, J., Milowsky, M. I., & Kim, W. Y. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0005 · Cited by 75
Liu, X., Sun, Q., Hou, H., Zhu, K., Wang, Q., Liu, H., Zhang, Q., Ji, L., & Li, D. (2018) · Medicine · doi:10.1097/md.0000000000012860 · Cited by 72
The impact of metformin use on survival in kidney cancer patients with diabetes: A meta-analysis
Li, Y., Hu, L., Xia, Q., Yuan, Y., & Mi, Y. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1548-4 · Cited by 38
The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma
Gudowska-Sawczuk, M., Kudelski, J., & Mroczko, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228582 · Cited by 36
Lu, L., Ahmed, F. S., Akin, O., Luk, L., Guo, X., Yang, H., Yoon, J., Hakimi, A. A., Schwartz, L. H., & Zhao, B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638185 · Cited by 31
George, S. M., Moore, S. C., Chow, W.-H., Schatzkin, A., Hollenbeck, A. R., & Matthews, C. E. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.04.012 · Cited by 28
Self-citationKim, N. Y., Jung, Y. Y., Yang, M. H., Chinnathambi, A., Govindasamy, C., Narula, A. S., Namjoshi, O. A., Blough, B. E., & Ahn, K. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.018 · Cited by 24
Metadata
- Authors
- Chow, W.-H., Dong, L. M., & Devesa, S. S.
- Venue
- Nature Reviews Urology
- Published
- 2010-05
- Volume
- 7
- Issue
- 5
- Pages
- 245-257
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W1976043651
- Cited by
- 1,384
- References
- 115
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.